elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q58732685-5F243C52-F061-446E-9668-DFC4569F1267
Q58732685-5F243C52-F061-446E-9668-DFC4569F1267
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58732685-5F243C52-F061-446E-9668-DFC4569F1267
Apatinib for patients with advanced or recurrent cervical cancer: study protocol for an open-label randomized controlled trial
P2860
Q58732685-5F243C52-F061-446E-9668-DFC4569F1267
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58732685-5F243C52-F061-446E-9668-DFC4569F1267
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d4e53bf9b46cda8ae0812e604f40bede10f134a5
P2860
Apatinib is effective for treatment of advanced hepatocellular carcinoma.